Variant report
Variant | nsv6011 |
---|---|
Chromosome Location | chr7:152769968-152815122 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:17)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:17 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:64251465..64252412-chr7:152789423..152790423,2 | MCF-7 | breast: | |
2 | chr7:152782260..152784480-chr7:152996047..152998703,2 | MCF-7 | breast: | |
3 | chr7:152777364..152780271-chr7:152784559..152786127,2 | K562 | blood: | |
4 | chr7:152778420..152780194-chr7:152788675..152790497,2 | K562 | blood: | |
5 | chr7:152777364..152780271-chr7:152784559..152786127,2 | K562 | blood: | |
6 | chr11:75863959..75864459-chr7:152795919..152796557,2 | MCF-7 | breast: | |
7 | chr7:152787813..152788395-chr7:152890287..152890803,2 | MCF-7 | breast: | |
8 | chr7:152786648..152788875-chr7:152810703..152813051,2 | K562 | blood: | |
9 | chr7:152793146..152798996-chr7:152800502..152805868,6 | K562 | blood: | |
10 | chr7:152788621..152790562-chr7:153104603..153106199,2 | K562 | blood: | |
11 | chr21:15652023..15652746-chr7:152811109..152812098,2 | MCF-7 | breast: | |
12 | chr7:152810422..152812239-chr7:153097689..153099428,2 | K562 | blood: | |
13 | chr7:152765162..152767226-chr7:152771503..152773527,2 | K562 | blood: | |
14 | chr7:152616673..152619076-chr7:152800039..152802738,2 | K562 | blood: | |
15 | chr7:152793146..152798996-chr7:152800502..152805868,6 | K562 | blood: | |
16 | chr7:152786648..152788875-chr7:152810703..152813051,2 | K562 | blood: | |
17 | chr7:152778420..152780194-chr7:152788675..152790497,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186112850 | chr7:152769974-152769975 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547971724 | chr7:152769982-152769983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566393200 | chr7:152770018-152770019 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1404591 | chr7:152770019-152770020 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs57733529 | chr7:152770031-152770032 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs573618928 | chr7:152770077-152770078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142299641 | chr7:152770086-152770087 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76883593 | chr7:152770087-152770088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555710141 | chr7:152770090-152770091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555889365 | chr7:152770121-152770122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189387729 | chr7:152770147-152770148 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544817119 | chr7:152770151-152770152 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181367186 | chr7:152770161-152770162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555921897 | chr7:152770194-152770195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs672960 | chr7:152770197-152770198 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs542938701 | chr7:152770211-152770212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561015277 | chr7:152770218-152770219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145938469 | chr7:152770236-152770237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550150926 | chr7:152770242-152770243 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565387504 | chr7:152770264-152770265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138547386 | chr7:152770291-152770292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548032837 | chr7:152770293-152770294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141566706 | chr7:152770306-152770307 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557741367 | chr7:152770322-152770323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536430271 | chr7:152770362-152770363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs548907740 | chr7:152770409-152770410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572857054 | chr7:152770411-152770412 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570252780 | chr7:152770465-152770466 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs674284 | chr7:152770470-152770471 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs7790428 | chr7:152770512-152770513 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs577338403 | chr7:152770535-152770536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538371782 | chr7:152770593-152770594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529354946 | chr7:152770610-152770611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555368138 | chr7:152770640-152770641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77720033 | chr7:152770650-152770651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542453996 | chr7:152770679-152770680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544266910 | chr7:152770692-152770693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561237606 | chr7:152770728-152770729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113729972 | chr7:152770765-152770766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368934415 | chr7:152770767-152770768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370772204 | chr7:152770775-152770776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185784021 | chr7:152770818-152770819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs479978 | chr7:152770866-152770867 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs532528374 | chr7:152770868-152770869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12703236 | chr7:152770879-152770880 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs144770623 | chr7:152770880-152770881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190086849 | chr7:152770882-152770883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548448287 | chr7:152770916-152770917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183049168 | chr7:152770920-152770921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531080113 | chr7:152770925-152770926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Autism | 20808228 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lobular carcinoma | 20920651 | CNVD |
Long-qt syndrome | 20920651 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Nasopharyngeal cancer | 20548289 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:152763600-152780600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr7:152768400-152779000 | Weak transcription | Fetal Kidney | kidney |
3 | chr7:152769400-152771200 | Enhancers | Brain Germinal Matrix | brain |
4 | chr7:152769800-152770400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr7:152770200-152770600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr7:152770200-152770600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr7:152771200-152772200 | Weak transcription | Brain Germinal Matrix | brain |
8 | chr7:152772200-152772600 | Enhancers | Brain Germinal Matrix | brain |
9 | chr7:152777600-152777800 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr7:152777800-152778000 | Flanking Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr7:152777800-152778000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr7:152779000-152779400 | Enhancers | Fetal Kidney | kidney |
13 | chr7:152780600-152781000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr7:152781000-152788800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr7:152782400-152792400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
16 | chr7:152783000-152783800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr7:152788600-152789000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr7:152788800-152789200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
19 | chr7:152788800-152789200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr7:152789200-152808400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr7:152808000-152808400 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
22 | chr7:152808400-152808600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr7:152810600-152811600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
24 | chr7:152810600-152811800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
25 | chr7:152810800-152811400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
26 | chr7:152811000-152811400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |